Teza Capital Management LLC Sells 89,993 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Teza Capital Management LLC cut its holdings in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 61.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 56,141 shares of the health services provider's stock after selling 89,993 shares during the period. Teza Capital Management LLC's holdings in Teladoc Health were worth $510,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Point72 Asset Management L.P. grew its position in shares of Teladoc Health by 33.6% during the 4th quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock worth $101,625,000 after purchasing an additional 2,813,568 shares in the last quarter. Maple Rock Capital Partners Inc. grew its holdings in shares of Teladoc Health by 189.5% during the 4th quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock worth $32,369,000 after purchasing an additional 2,331,000 shares in the last quarter. Vanguard Group Inc. increased its position in shares of Teladoc Health by 5.9% in the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider's stock worth $167,830,000 after purchasing an additional 1,029,829 shares during the period. Renaissance Technologies LLC lifted its position in Teladoc Health by 15.5% during the fourth quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider's stock worth $51,582,000 after purchasing an additional 763,265 shares during the period. Finally, Nisa Investment Advisors LLC grew its stake in Teladoc Health by 20,936.8% during the fourth quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider's stock worth $3,874,000 after buying an additional 424,180 shares in the last quarter. 76.82% of the stock is owned by institutional investors.

Teladoc Health Stock Down 2.8%

Shares of Teladoc Health stock opened at $7.31 on Tuesday. The firm has a market cap of $1.28 billion, a price-to-earnings ratio of -1.27 and a beta of 1.82. Teladoc Health, Inc. has a one year low of $6.35 and a one year high of $15.21. The stock's 50-day moving average is $7.55 and its 200 day moving average is $9.35. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The firm had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. Equities research analysts anticipate that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Insider Activity at Teladoc Health

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the firm's stock in a transaction on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the transaction, the insider now directly owns 64,308 shares in the company, valued at approximately $541,473.36. This trade represents a 14.62% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.58% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on TDOC shares. Royal Bank of Canada upped their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. Wells Fargo & Company cut their target price on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating for the company in a research note on Thursday, May 8th. Piper Sandler lowered their price target on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating for the company in a report on Thursday, February 27th. Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a research note on Thursday, May 1st. Finally, Jefferies Financial Group dropped their target price on Teladoc Health from $10.00 to $8.00 and set a "hold" rating for the company in a research report on Monday, April 21st. Twelve analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, Teladoc Health currently has a consensus rating of "Hold" and an average target price of $9.71.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.